Figures & data
Table 1 Baseline demographic and clinical characteristics of the unmatched and matched intervention and control 3- and 6-month follow-up groups
Table 2 Baseline primary pain complaint for the unmatched and matched intervention and control 3- and 6-month follow-up groups
Table 3 Baseline Brief Pain Inventory scores for overall severity, severity questions, overall interference, and interference questions for the unmatched and matched intervention and control 3- and 6-month follow-up groups
Figure 1 Change from baseline in overall mean pain severity and interference scores within the (A) 3- and (B) 6-month unmatched intervention follow-up group.
Figure 2 Mean change from baseline in (A) overall pain severity and (B) interference scores between the 3- and 6-month follow-up unmatched intervention and control groups.
Figure 3 Mean change from baseline in (A) overall pain severity and (B) interference scores between the 3- and 6-month matched intervention and control groups.
Figure 4 Percent change from baseline in the use of concurrent pain medications between the (A) 3- and (B) 6-month unmatched intervention and control groups.
Figure 5 Percent change from baseline in the use of concurrent pain medications between the (A) 3- and (B) 6-month matched intervention and control groups.
